BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/24/2018 1:07:06 AM | Browse: 780 | Download: 1075
 |
Received |
|
2018-09-18 00:54 |
|
Peer-Review Started |
|
2018-09-18 06:21 |
|
To Make the First Decision |
|
2018-10-12 00:31 |
|
Return for Revision |
|
2018-10-12 00:49 |
|
Revised |
|
2018-11-20 06:52 |
|
Second Decision |
|
2018-11-23 08:11 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-11-24 04:38 |
|
Articles in Press |
|
2018-11-24 04:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-11-30 14:14 |
|
Typeset the Manuscript |
|
2018-12-17 00:31 |
|
Publish the Manuscript Online |
|
2018-12-24 01:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Research & Experimental Medicine |
| Manuscript Type |
Case Report |
| Article Title |
Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zai-Wei Song, Yu-Chen Pan, Zhen-Cheng Huang, Wen-Xi Liu, Rong-Sheng Zhao, Hong-Mei Jing and Fei Dong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fei Dong, MD, Doctor, Department of Hematology, Peking University Third Hospital, 49 North Garden Rd., Haidian District, Beijing 100191, China. knowflying@163.com |
| Key Words |
Posaconazole; Hyperbilirubinemia; Liver injury; Acute myeloid leukemia; Case report |
| Core Tip |
Posaconazole is safe and tolerable in most cases and posaconazole-associated severe hyperb-ilirubinemia is usually very rare. For patients with hematological malignancy who develop severe infection following chemotherapy, combination of anti-infective drugs may contribute to higher risk of posaconazole-induced severe liver injury of cholestatic type. There¬fore, for patients with hematological malignancy, liver and renal function should be monitored closely before and during the administration of posaconazole. |
| Publish Date |
2018-12-24 01:07 |
| Citation |
Song ZW, Pan YC, Huang ZC, Liu WX, Zhao RS, Jing HM, Dong F. Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report. World J Clin Cases 2018; 6(16): 1206-1209 |
| URL |
https://www.wjgnet.com/2307-8960/full/v6/i16/1206.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v6.i16.1206 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
